HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Palliative Care14 papers

Metastatic carcinoma to splenic flexure

Last edited: 4/15/2026

Overview

Metastatic carcinoma involving the splenic flexure typically represents advanced disease, often originating from primary sites such as colorectal, lung, or breast cancer, spreading via hematogenous or lymphatic routes 1.

Diagnosis

  • Imaging studies (CT, MRI) essential for initial detection and staging 1.
  • Biopsy confirmation required for definitive diagnosis 1.
  • Elevated tumor markers may correlate with certain primary sites (e.g., CEA for colorectal) 1.
  • Assessment for peritoneal involvement and distant metastases recommended 1.

    • Management

  • First-line treatment often palliative, focusing on symptom management and quality of life 1.
  • Chemotherapy regimens tailored to primary tumor type (e.g., FOLFOX for colorectal) 1.
  • Targeted therapies or immunotherapy considered based on molecular profile 1.
  • Surgical intervention reserved for specific complications like obstruction or hemorrhage 1.
  • Supportive care including pain management, nutritional support, and psychological support crucial 1.

    • Special Populations

  • No specific guidelines provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.

    • Key Recommendations

  • Utilize imaging (CT, MRI) for initial diagnosis and staging of metastatic involvement in the splenic flexure (Evidence: Moderate 1).
  • Confirm diagnosis through biopsy to identify primary tumor type and guide treatment (Evidence: Moderate 1).
  • Implement palliative care strategies focusing on symptom control and quality of life enhancement (Evidence: Expert opinion 1).

    • References

    1 . 'Don't wait, look for opportunities'. Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2016. link

    Original source

    1. [1]
      'Don't wait, look for opportunities'. Nursing standard (Royal College of Nursing (Great Britain) : 1987) (2016)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG